Source: SYS-CON MEDIA

viDA: Partnership Between The Centre for Drug Research and Development (CDRD) and viDA Therapeutics Leading to New Commercialized Therapies

Two British Columbia-headquartered biotech organizations are expanding their successful collaboration to develop much needed treatments for patients living with Discoid Lupus Erythmatosus (DLE).read more

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Alistair Duncan's photo - President & CEO of viDA

President & CEO

Alistair Duncan

CEO Approval Rating

79/100

Read more